Establishment Labs Appoints Highly Experienced MedTech Executive Taylor Harris to Board
ESTA has more than doubled off its 52-week low of $33.35 on elevated volume (9.0× avg).
Summary
Establishment Labs appointed Taylor Harris, a highly experienced medical technology executive with a strong M&A background, to its Board of Directors, enhancing strategic and financial oversight.
Key Events · Executive and Board Changes · ESTA
-
New Director Appointed
Taylor Harris was appointed to the Board of Directors, effective June 24, 2026, to serve until the 2027 annual meeting of shareholders.
-
Extensive Industry Experience
Mr. Harris brings over 25 years of experience in corporate finance, executive leadership, and board governance, including prior roles as CEO of Cutera and CFO for MyoKardia, Zeltiq Aesthetics, and Thoratec, all of which were acquired in multi-billion dollar transactions.
-
Key Committee Assignments
Mr. Harris will serve as a member of both the Audit Committee and the Nominating and Corporate Governance Committee, with all members of these committees determined to be independent.
Analysis · ESTA · Industrial Applications And Services
Establishment Labs has appointed Taylor Harris, a seasoned executive with over 25 years of experience in corporate finance, executive leadership, and board governance across healthcare and medical technology, to its Board of Directors. Harris's background includes CFO roles at companies acquired for billions (MyoKardia, Zeltiq Aesthetics, Thoratec) and a CEO position at Cutera. His expertise in M&A, strategic growth, and financial oversight is a significant addition to the board, particularly as the company trades near its 52-week high and recently secured substantial financing.
At the time of this filing, ESTA was trading at $89.99 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.6B. The 52-week trading range was $33.35 to $90.50. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.